🔗 Share this article

A shadow economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Investigational Drug Acquiring Popularity Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are urged to contact these accounts privately for supplier links, while also receiving discount codes.

Active Trade on Social Networks

Additionally, a flourishing trade exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and assertions of rapid UK delivery. Sellers market the substance there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Professionals Voice Concerns

However, doctors and chemists have cautions that the distribution of what remains an unapproved medication in the UK is a cause for concern and could result in individuals administering substances of unknown origin.

Some experts stated the demand for the experimental drug could be connected to the rising cost of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for human use under the British medical regulations.

Several influencers try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate pharmaceutical, advertising, and customer laws, risking fines, prosecution or imprisonment.

Service Response and Content Removal

According to TikTok, the service has removed violative content and prohibited associated keywords and query recommendations. The company stated it was dedicated to keeping the service secure and investing in enhancing enforcement strategies.

Online Marketplace Operations

Investigations also found groups with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays channels with thousands of members, populated with images of weight loss, positive testimonials and step-by-step guides for mixing or administering at home.

After moments of entering one group, a vendor shared contact information, where most purchases take place. The vendor provided an instruction manual and promised delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about weight, medical conditions or past usage.

Item Details and Pricing

Inside these groups, messages show dark colored parcels with postal service labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or pre-filled injectors usually sold at £160 for 20 milligrams. When asked how long a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service said it regularly monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they can’t verify. Even if the research behind this drug is sound, these digital versions may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she said.

Her staff has already seen individuals harmed by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational product not yet approved … may subject patients to possibly significant health risks”.